Manuscript citation: Lyles RDZ, Martinez MJ, Sherman B, Schürer S, Burnstein KL (2023) Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens. PLoS ONE 18(10): e0287126. https://doi.org/10.1371/journal.pone.0287126
License: This is an open access collection distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Protocol status: WorkingWe use this collection and it's working
Created: March 01, 2023
Last Modified: June 02, 2023
Collection Integer ID: 77846
Keywords: live-cell imaging, endpoint cell viability, 96-well plate drug screens, integrated drug screen, drug efficacy across multiple cell line, cell imaging platform, active cancer therapeutic, cell imaging, future cancer research study, single drug screen, drug screen, well plate drug screen, glo endpoint viability assay, cancer model system, incucyte zoom, cell viability, drug efficacy, cell line, cytotoxic effect, panel of cell line, screen compound, well plate cell growth condition, cell specific morphological change, multiple cell line